What can we do about osteoarthritis?
Lohmander, Stefan LU
(2000)
In Arthritis Research & Therapy
2(2).
p.95-100
- Abstract
- Osteoarthritis is complex in genetics, pathogenesis, monitoring and treatment. Current treatment of osteoarthritis does not influence progression. Much could be gained by more effective low-tech-low-cost treatment. However, many patients have rapidly progressive disease, multiple joint involvement, and severe disease. We need to clarify the genetics of osteoarthritis, identify those at risk for progression and severe disease, and identify molecular processes critical for joint survival and failure. Will saving the cartilage improve patient pain and function? Effective outcome measures are needed to accelerate testing of new treatments. Further improvement is needed in joint implant technology to decrease costs, wear and loosening.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/131764
- author
- Lohmander, Stefan
LU
- organization
- publishing date
- 2000
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Arthritis Research & Therapy
- volume
- 2
- issue
- 2
- pages
- 95 - 100
- publisher
- BioMed Central (BMC)
- external identifiers
-
- scopus:0034467087
- ISSN
- 1465-9913
- DOI
- 10.1186/ar74
- language
- English
- LU publication?
- yes
- id
- e5e5d896-dbd7-4fca-a803-4da4d1f51109 (old id 131764)
- alternative location
- http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11094419
- date added to LUP
- 2016-04-01 16:06:08
- date last changed
- 2023-01-04 21:21:28
@article{e5e5d896-dbd7-4fca-a803-4da4d1f51109,
abstract = {{Osteoarthritis is complex in genetics, pathogenesis, monitoring and treatment. Current treatment of osteoarthritis does not influence progression. Much could be gained by more effective low-tech-low-cost treatment. However, many patients have rapidly progressive disease, multiple joint involvement, and severe disease. We need to clarify the genetics of osteoarthritis, identify those at risk for progression and severe disease, and identify molecular processes critical for joint survival and failure. Will saving the cartilage improve patient pain and function? Effective outcome measures are needed to accelerate testing of new treatments. Further improvement is needed in joint implant technology to decrease costs, wear and loosening.}},
author = {{Lohmander, Stefan}},
issn = {{1465-9913}},
language = {{eng}},
number = {{2}},
pages = {{95--100}},
publisher = {{BioMed Central (BMC)}},
series = {{Arthritis Research & Therapy}},
title = {{What can we do about osteoarthritis?}},
url = {{https://lup.lub.lu.se/search/files/4568224/624252.pdf}},
doi = {{10.1186/ar74}},
volume = {{2}},
year = {{2000}},
}